Est autorizado para el tratamiento de la diabetes tipo 2, con o sin la ayuda de otros medicamentos, cuando la dieta y el ejercicio no son suficientes para controlar la glucemia (el azcar o la glucosa en sangre)
Hormone injections are key in IVF
26,27,30 In a patient starting with fat in their liver, the hepatic compartment alone can account for a meaningful fraction of the total lean mass change that DXA reports
To view a copy of this license, visit About this article Cite this article Scott, M., Billiar, T
actinium-225 alpha emitter / OncologyPancreatic cancerPhase 1planned 3assets Budoprutug IVCD19 / monoclonal antibody / immune-mediated diseasesPrimary Membranous NephropathyPhase 2Immune ThrombocytopeniaPhase 1Systemic Lupus ErythematosusPhase 1 Budoprutug SCCD19 / monoclonal antibody / immune-mediated diseasesAutoimmune DiseasePhase 1healthy volunteer trial CLYM116CLYM116 / APRIL / monoclonal antibody / immune-mediated diseasesIgA NephropathyPhase 1healthy volunteer trial 3assets cleminorextonORX750 / OX2R / oral orexin receptor 2 agonist / Sleep-wake disordersNarcolepsy Type 1 (NT1)Phase 2aactiveNarcolepsy Type 2 (NT2)Phase 2aactiveIdiopathic Hypersomnia (IH)Phase 2aactive ORX142ORX142 / OX2R / oral orexin receptor 2 agonist / Neurology/neurodegenerative disordersNeurological & neurodegenerative disordersPhase 1active ORX489ORX489 / OX2R / oral orexin receptor 2 agonist / NeuropsychiatryNeuropsychiatric disordersPreclinicalactive 3assets CTIM-76CTIM-76 / CLDN6 x CD3 / TCE bispecific antibody / Oncologyrecurrent ovarian cancer and other advanced solid tumorsPhase 1ongoingplatinum-resistant ovarian cancerPhase 1FDA Fast TrackUS CT-95CT-95 / MSLN x CD3 / TCE bispecific antibody / Oncologyadvanced solid tumorsPhase 1ongoing CT-202CT-202 / Nectin-4 x CD3 / TCE bispecific antibody / OncologyNectin-4-positive solid tumorsPhase 1planned
Studied for Wound Healing GHK Cu has been studied for its potential role in tissue repair and wound healing, making it interesting for both anti aging and recovery goals
